4.The surgical management of extensive nasopharyngeal angiofibroma with combined intracranial and extracranial approach.
Chul Hee LEE ; Ha Won JUNG ; Hun Jong DONG ; Yeong Seok YUN ; Won Seok YU ; Sung Hwa HONG
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(2):376-386
No abstract available.
Angiofibroma*
5.Combined Treatment with Metallic Stent Placement and Radiotherapy in Malignant Biliary Obstruction.
Chul Yong KIM ; Yun Hwan KIM ; Taek Soo RHO ; Chang Hee LEE ; Hoe Seok JUNG
Journal of the Korean Radiological Society 1994;31(6):1045-1049
PURPOSE: To evaluate the efficacy of combined treatment of metallic biliary stent placement and radiotherapy in malignant biliary obstruction. MATERIALS AND METHODS: Between January 1992 and February 1994, 22 patients with malignant biliary obstruction were treated with metallic biliary stent placement and radiotherapy. The causes of the obstruction included cholangiocarcinoma(n=14), gallbladder carcinoma(n=4), colon cancer(n=2), pancreatic head cancer (n=1), and stomach cancer(n=1). According to the sites of obstruction level, patient were divided into 2 groups; hilar obstruction(n=18) and common bile duct obstruction(n=4). The patients received dose of 45 Gray/18 fraction by external radiotherapy and 20Gy/8f by high dose rate brachytherapy with iridium--192 source through percutaneous transhepatic biliary drainage(PTBD) catheter. The duration of stent patency after placement, survival period and survival rate by Kaplan Meier method were calculated in dead and alive patients, respectively. RESULTS: In all 22 patients, the duration of stent patency was 5.5(1.3--18.5)months. Survival periods after stent placement and PTBD were 5.3(2.0--8.5 )months and 7.9(4.0--14.7)months respectively in 9 dead patients and 7.7(1.3--21.0)months and 9.5(2.3--23.0)months in 13 alive patients. In all 22 patients, the survival rates in 6, 12 and 18 months were 78.9%, 47.5 % and 35.6 %, respectively. CONCLUSIONS: The results with combined metallic biliary stent placement and radiotherapy for the palliative treatment of malignant biliary obstruction in this study was more favorable, as compared with those of the other authors with only metallic biliary stent placement.
Brachytherapy
;
Catheters
;
Colon
;
Common Bile Duct
;
Gallbladder
;
Head and Neck Neoplasms
;
Humans
;
Palliative Care
;
Radiotherapy*
;
Stents*
;
Stomach
;
Survival Rate
6.A Feasibility Study of an Exercise Intervention Based on Self-efficacy Theory among Overweight and Obese College Students in Korea.
Eun Seok CHA ; Yun A SHIN ; Hee Young KIM
Journal of Korean Academy of Community Health Nursing 2008;19(4):704-714
PURPOSE: This study explored the feasibility of a 12 week self-efficacy based exercise intervention for overweight and obese college students. METHOD: A repeated measure, 4-group randomized controlled design was used. Students were recruited from two universities, in Seoul, Korea using: (1) flyers either on the campus bulletin boards or in campus restrooms; (2) advertisement on campus e-board; and (3) self-referral. Inclusion criteria were: (1) Korean college students aged 18 to 29; (2) BMI >23; (3) viscerally obese; and (4) accessible to a phone and a computer. Participants completed three self-reported questionnaires: socio-demographic questionnaire (at the baseline), Exercise Self-Efficacy Scale (at the baseline and 12th week), and Physical Fitness sub-subscale (at the baseline and 12th week). Additionally, physiological data (height, weight, blood pressure) were collected at the baseline and 12th week. Descriptive statistics and a two-way mixed ANOVA were performed using SPSS12.0. RESULTS: No significant group difference was observed. However, students with increased exercise self-efficacy during the program showed better physical fitness in the 12th week. When students' physical fitness was enhanced, the physiological factors were improved. CONCLUSIONS: Self-efficacy based exercise intervention may be applicable and acceptable to the college students. It is necessary to conduct a replicated study with a larger sample and an elongated intervention period.
Feasibility Studies*
;
Humans
;
Korea
;
Obesity
;
Overweight*
;
Physical Fitness
;
Self Efficacy
;
Seoul
;
Surveys and Questionnaires
7.The lateral facial approach for the lateral orbital wall fracturewith blindness.
Chul Hee LEE ; Sung Wha HONG ; Yeong Seok YUN ; Keun Ho CHANG
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(3):616-620
No abstract available.
Blindness*
;
Orbit*
8.Quantitative assessment of the diameters of tricuspid valve, mitral valve and great arteries in the normal human fetus.
Jung Yun CHOI ; Kyung Hee PARK ; Chung Il NOH ; Yong Soo YUN ; I Seok KANG ; Eun Sook HAN
Journal of the Korean Pediatric Society 1992;35(11):1566-1572
No abstract available.
Arteries*
;
Echocardiography
;
Fetus*
;
Heart
;
Humans*
;
Mitral Valve*
;
Tricuspid Valve*
9.A Case with Neuro-Sweet Syndrome.
Sung Hee YUN ; Seok Beom KWON ; Hee Jung SEO ; San JUNG ; Sung Hee HWANG ; Byung Chul LEE
Journal of the Korean Neurological Association 2005;23(5):706-708
Sweet's syndrome, or acute febrile neutrophilic dermatosis, is an unusual disease characterized by fever, leukocytosis, and distinctive skin lesions. Common complications include arthralgia, arthritis, conjunctivitis, and iridocyclitis. However, the involvement of the central nervous system in this disease, termed `neuro-Sweet syndrome' is rarely reported. We present a patient with recurrent encephalitis for 15 years, accompanied with neutrophilic dermatosis, and characterized by HLA-B54 and Cw1, with good responsiveness to corticosteroid.
Arthralgia
;
Arthritis
;
Central Nervous System
;
Conjunctivitis
;
Encephalitis
;
Fever
;
Humans
;
Iridocyclitis
;
Leukocytosis
;
Neutrophils
;
Skin
;
Skin Diseases
;
Sweet Syndrome
10.Influence of Transforming Growth Factor-alpha on Expression of Matrix Metalloproteinase-2, 9 and Epidermal Growth Factor Receptor Gene in the Mouse Blastocysts.
Jeong Hee KIM ; Seok Ho HONG ; Hee Young NAH ; Ji Yun LEE ; Hee Dong CHAE ; Chung Hoon KIM ; Byung Moon KANG ; In Ha BAE
Korean Journal of Fertility and Sterility 2001;28(3):173-182
No abstract available.
Animals
;
Blastocyst*
;
Epidermal Growth Factor*
;
Matrix Metalloproteinase 2*
;
Mice*
;
Receptor, Epidermal Growth Factor*